Phase I trial of ADMVA vaccine begins in New York.
D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D005814:Genes, Viral; D006678:HIV / Q000235:genetics; D015658:HIV Infections / Q000517:prevention & control*; D018023:HIV Seronegativity; D006801:Humans; D009518:New York
D016915:AIDS Vaccines